View Exam | PowerPak

1. What is the 'optimal' triglyceride (TG) level according to the 2011 American Heart Association Scientific Statement on Treatment of hypertriglyceridemia (HTG)?

A. <70 mg/dL B. <100 mg/dL C. <150 mg/dL D. <200 mg/dL E. <250 mg/dL

2. Why is it important to measure non-HDL-C in patients with HTG?

A. Non-HDL-C helps measure atherogenic effects of non-LDL particles B. Non-HDL-C is a much stronger predictor of CHD risk than LDL-C C. LDL-C is often misleadingly low, despite high LDL particle number, due to decreased cholesterol content of LDL particles D. At a given non-HDL-C level, there is little or no association between LDL-C and CHD E. All of the above

3. According to ATP III, which of the following constitutes a TG level where one should consider the non-HDL-C goal in addition to the LDL-C goal?

A. 100 – 199 mg/dL B. 150 – 249 mg/dL C. 200 – 499 mg/dL D. ≥500 mg/dL

4. Which of the following is not indicated for very high TG levels?

A. Fenofibrate B. Extended-release niacin C. Statins D. Omega-3 fatty acids E. Omega-6 fatty acids

5. What is the recommended dose for prescription omega-3 fatty acids agents to reduce TG levels?

A. 1 gm/day B. 2 gm/day C. 4 gm/day D. 6 gm/day

6. Which one of the following clinical trials (study drug) met or exceeded their primary endpoint?

A. FIELD (fenofibrate) B. ACCORD (simvastatin+fenofibrate) C. AIM-HIGH (statin+extended-release niacin) D. HPS2-THRIVE (laropiprant+extended-release niacin) E. JELIS (eicosapentaenoic acid [EPA-only])

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. What is the 'optimal' triglyceride (TG) level according to the 2011 American Heart Association Scientific Statement on Treatment of hypertriglyceridemia (HTG)?

2. Why is it important to measure non-HDL-C in patients with HTG?

3. According to ATP III, which of the following constitutes a TG level where one should consider the non-HDL-C goal in addition to the LDL-C goal?

4. Which of the following is not indicated for very high TG levels?

5. What is the recommended dose for prescription omega-3 fatty acids agents to reduce TG levels?

6. Which one of the following clinical trials (study drug) met or exceeded their primary endpoint?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. What is the 'optimal' triglyceride (TG) level according to the 2011 American Heart Association Scientific Statement on Treatment of hypertriglyceridemia (HTG)?

2. Why is it important to measure non-HDL-C in patients with HTG?

3. According to ATP III, which of the following constitutes a TG level where one should consider the non-HDL-C goal in addition to the LDL-C goal?

4. Which of the following is not indicated for very high TG levels?

5. What is the recommended dose for prescription omega-3 fatty acids agents to reduce TG levels?

6. Which one of the following clinical trials (study drug) met or exceeded their primary endpoint?

« Return to Activity

Customers who Purchased
this Activity also Purchased